FindTrial
Sign In

Manufacturing and storage of alfa-galactosylceramide-pulsed dendritic cells derived from peripheral blood of healthy volunteers

Manufacturing and storage of alfa-galactosylceramide-pulsed dendritic cells derived from peripheral blood of healthy volunteers - Manufacturing and storage of alfa-galactosylceramide-pulsed dendritic cells

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040906
Enrollment
20
Registered
2020-06-26
Start date
2019-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy volunteers with no history of present or past cancer treatment 2) Age:20 year-old and above 3) Weight:Male 45kg and above; Female 40kg and above 4) Hemoglobin Content: 12.0g/dL and above 5) After receiving sufficient explanation on participation in this study, each participant acknowledged s/he had understood the terms and conditions of this study, and signed study participant agreement of his/her own free will.

Exclusion criteria

Exclusion criteria: 1) One who has a heart disease, for which we can not perform apheresis 2) One who is taking or injecting corticosteroids 3) One that the principal investigator determines to be inappropriate as a subject

Countries

Japan

Contacts

Public ContactShinichiro Motohashi

Graduate school of Medicine, Chiba University Department of Medical Immunology

motohashi@faculty.chiba-u.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026